1. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635-48. [
DOI:10.1016/S0140-6736(20)31288-5] [
PMID]
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. [
DOI:10.3322/caac.21660] [
PMID]
3. Dykes IM, Emanueli C. Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. Genom Proteom Bioinform. 2017;15(3):177-86. [
DOI:10.1016/j.gpb.2016.12.005] [
PMID] [
PMCID]
4. Ciafrè SA, Russo M, Michienzi A, Galardi S. Long Noncoding RNAs and Cancer Stem Cells: Dangerous Liaisons Managing Cancer. Int J Mol Sci. 2023;24(3):1828. [
DOI:10.3390/ijms24031828] [
PMID] [
PMCID]
5. Fischer M, Riege K, Hoffmann S. The landscape of human p53‐regulated long non‐coding RNAs reveals critical host gene co‐regulation. Mol Oncol. 2023;17(7):1263-79. [
DOI:10.1002/1878-0261.13405] [
PMID] [
PMCID]
6. Bao X, Wu H, Zhu X, Guo X, Hutchins AP, Luo Z, et al. The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res. 2015;25(1):80-92. [
DOI:10.1038/cr.2014.165] [
PMID] [
PMCID]
7. Huang Y, Yi Q, Feng J, Xie W, Sun W, Sun W. The role of lincRNA-p21 in regulating the biology of cancer cells. Hum Cell. 2022;35(6):1640-9. [
DOI:10.1007/s13577-022-00768-4] [
PMID]
8. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142(3):409-19. [
DOI:10.1016/j.cell.2010.06.040] [
PMID] [
PMCID]
9. Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, Sarma K, et al. LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint. Mol Cell. 2014;54(5):777-90. [
DOI:10.1016/j.molcel.2014.04.025] [
PMID] [
PMCID]
10. Jia M, Jiang L, Wang YD, Huang JZ, Yu M, Xue HZ. lincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial-mesenchymal transition. Hepatol Res. 2016;46(11):1137-44. [
DOI:10.1111/hepr.12659] [
PMID]
11. Yu F, Guo Y, Chen B, Shi L, Dong P, Zhou M, et al. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p. Cell Physiol Biochem. 2017;41(5):1970-80. [
DOI:10.1159/000472410] [
PMID]
12. Chen S, Liang H, Yang H, Zhou K, Xu L, Liu J, et al. LincRNa-p21: function and mechanism in cancer. Med Oncol. 2017;34(5):98. [
DOI:10.1007/s12032-017-0959-5] [
PMID]
13. Khalili M, Vasei M, Khalili D, Alimoghaddam K, Sadeghizadeh M, Mowla SJ. Downregulation of the Genes Involved in Reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in Gastric Adenocarcinoma. J Gastrointest Cancer. 2015;46(3):251-8. [
DOI:10.1007/s12029-015-9695-2] [
PMID]
14. Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18-27. [
DOI:10.1016/j.neo.2022.01.001] [
PMID] [
PMCID]
15. Hall JR, Messenger ZJ, Tam HW, Phillips SL, Recio L, Smart RC. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes. Cell Death Dis. 2015;6(3):e1700. [
DOI:10.1038/cddis.2015.67] [
PMID] [
PMCID]
16. Yang N, Fu Y, Zhang H, Sima H, Zhu N, Yang G. LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma. Oncotarget. 2015;6(29):28151-63. [
DOI:10.18632/oncotarget.4661] [
PMID] [
PMCID]
17. Zhai H, Fesler A, Schee K, Fodstad O, Flatmark K, Ju J. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin Colorectal Cancer. 2013;12(4):261-6. [
DOI:10.1016/j.clcc.2013.06.003] [
PMID]
18. Işın M, Uysaler E, Özgür E, Köseoğlu H, Şanlı Ö, Yücel Ö B, et al. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front Genet. 2015;6:168. [
DOI:10.3389/fgene.2015.00168] [
PMID] [
PMCID]
19. Wang X, Ruan Y, Wang X, Zhao W, Jiang Q, Jiang C, et al. Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer. Cell Prolif. 2017;50(2):e12318. [
DOI:10.1111/cpr.12318] [
PMID] [
PMCID]
20. Isin M, Ozgur E, Cetin G, Erten N, Aktan M, Gezer U, et al. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta. 2014;431:255-9. [
DOI:10.1016/j.cca.2014.02.010] [
PMID]
21. Yang F, Zhang H, Mei Y, Wu M. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect. Mol Cell. 2014;53(1):88-100. [
DOI:10.1016/j.molcel.2013.11.004] [
PMID]
22. Chen L, Yuan D, Yang Y, Ren M. LincRNA-p21 enhances the sensitivity of radiotherapy for gastric cancer by targeting the β-catenin signaling pathway. J Cell Biochem. 2019;120(4):6178-87. [
DOI:10.1002/jcb.27905] [
PMID]
23. Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, et al. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer. 2015;14(1):28. [
DOI:10.1186/s12943-015-0295-3] [
PMID] [
PMCID]
24. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature. 2009;460(7259):1140-4. [
DOI:10.1038/nature08311] [
PMID] [
PMCID]
25. Ma X, Yan W, Xu P, Ma L, Zan Y, Huang L, et al. LncRNA-p21 suppresses cell proliferation and induces apoptosis in gastric cancer by sponging miR-514b-3p and up-regulating ARHGEF9 expression. Biol Chem. 2022;403(10):945-58. [
DOI:10.1515/hsz-2022-0153] [
PMID]
26. Chen Y, Wei G, Xia H, Yu H, Tang Q, Bi F. Down regulation of lincRNA-p21 contributes to gastric cancer development through Hippo-independent activation of YAP. Oncotarget. 2017;8(38):63813-24. [
DOI:10.18632/oncotarget.19130] [
PMID] [
PMCID]